Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Clinical trial NCT02815007 · UNKNOWN
Trial details
- NCT number
- NCT02815007
- Sponsor
- Yuankai Shi
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.